Universitätsklinikum Frankfurt am Main (KGU)

First report from the German COVID-19 autopsy registry (2022) von Stillfried S, Bülow RD, Röhrig R, Boor P, Böcker J, Schmidt J, Tholen P, et al. Journal article S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms – Kurzversion 2.00 – Juni 2021, AWMF-Registernummer: 032-053OL (2022) Sabrina V, Michael B, Joerg A, Peter B, Wolf B, Susanne B, Thomas B, et al. Journal article S3-Guideline: Diagnosis and Therapy of Hepatocellular Carcinoma (2022) Sabrina V, Michael B, Joerg A, Peter B, Wolf B, Susanne B, Thomas B, et al. Journal article Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study (2022) Woelber L, Hampl M, Eulenburg CZ, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Journal article Best Practice Guideline - DEGUM Recommendations on Breast Ultrasound - Part I - Examination technique, DEGUM ultrasound criteria, and documentation (2021) Bader W, Vogel-Minea CM, Blohmer JU, Duda V, Eichler C, Fallenberg E, Farrokh A, et al. Journal article Different Prevalence of Alarm, Dyspeptic and Reflux Symptoms in Patients with Cardia and Non-cardia Gastric Cancer (2021) Franck C, Zimmermann N, Goni E, Lippert H, Ridwelski K, Kruschewski M, Kreuser N, et al. Journal article Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021) Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al. Journal article The German Society of Residents in Urology Full speed ahead: The new Board of the German Society of Residents in Urology 2021/22 (2021) Siech C, Neutzer M, Zehe , Moharam N, Konopka M, Bellut L Journal article, Editorial Evaluation of a clinical decision support system for rare diseases: a qualitative study (2021) Schaaf J, Sedlmayr M, Sedlmayr B, Prokosch HU, Storf H Journal article Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution